The East Carolina Breast Center phase II trial of neoadjuvant metronomic chemotherapy in triple-negative breast cancer.
R. E. Raab
No relevant relationships to disclose
P. R. Walker
No relevant relationships to disclose
L. S. Bellin
No relevant relationships to disclose
J. H. Wong
No relevant relationships to disclose